Abstract |
A randomized, blinded, pilot study of influenza vaccine administered to children attending day care centers was conducted during the 1996-1997 winter. Vaccine efficacy in preventing serologically proven influenza virus infection was 0.45 (95% confidence limit [CL]: -0.02, 0.69) for influenza B and 0.31 (95% CL: -0.95, 0.73) for influenza A(H3N2). For both influenza A(H3N2) and B, children without preexisting hemagglutination inhibition (HI) antibody to these antigens had lower antibody responses to vaccine, were less likely to develop a serological response, and were more likely to develop serological evidence of influenza infection. Although there were no reductions in respiratory or febrile respiratory illnesses among all vaccinated children, there was a trend for reductions in such illnesses among vaccinated children with preexisting HI antibodies to influenza A(H3N2) and B. Therefore, immunologic priming in young children may be important for vaccine response and for protection against infection. Larger studies are needed in other influenza seasons to assess vaccine efficacy and clinical effectiveness.
|
Authors | E S Hurwitz, M Haber, A Chang, T Shope, S T Teo, J S Giesick, M M Ginsberg, N J Cox |
Journal | The Journal of infectious diseases
(J Infect Dis)
Vol. 182
Issue 4
Pg. 1218-21
(Oct 2000)
ISSN: 0022-1899 [Print] United States |
PMID | 10979921
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antibodies, Viral
- Hepatitis A Vaccines
- Influenza Vaccines
- Vaccines, Inactivated
|
Topics |
- Antibodies, Viral
(blood)
- Child Day Care Centers
- Child, Preschool
- Double-Blind Method
- Hemagglutination Inhibition Tests
- Hepatitis A Vaccines
- Humans
- Influenza A virus
(immunology)
- Influenza B virus
(immunology)
- Influenza Vaccines
(immunology, therapeutic use)
- Influenza, Human
(immunology, prevention & control)
- Pilot Projects
- Vaccines, Inactivated
(immunology, therapeutic use)
|